HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
39 hedge funds and large institutions have $9M invested in Hepion Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+2
Holders Change %
+5.41%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
10
Closed
7
Calls
$538K
Puts
$115K
Net Calls
+$423K
Net Calls Change
-$697K
Top Buyers
1 |
Bank of New York Mellon
New York
|
+$79K |
2 |
Renaissance Technologies
New York
|
+$57K |
3 |
VF
Virtu Financial
New York
|
+$57K |
4 |
AC
Aristides Capital
Louisville,
Kentucky
|
+$56K |
5 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$54.8K |